athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction that occurred on Friday, October 20th. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Brandon H. Hull also recently made the following trade(s):

  • On Friday, September 1st, Brandon H. Hull sold 800 shares of athenahealth stock. The shares were sold at an average price of $140.95, for a total transaction of $112,760.00.
  • On Tuesday, August 1st, Brandon H. Hull sold 800 shares of athenahealth stock. The shares were sold at an average price of $140.01, for a total transaction of $112,008.00.

athenahealth, Inc. (NASDAQ:ATHN) traded down 0.17% during trading on Tuesday, reaching $126.40. 671,352 shares of the company’s stock traded hands. The firm’s 50 day moving average price is $124.95 and its 200-day moving average price is $130.67. athenahealth, Inc. has a one year low of $90.11 and a one year high of $158.66. The stock has a market cap of $5.05 billion, a P/E ratio of 160.41 and a beta of 1.76.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. During the same period in the prior year, the company posted $0.60 EPS. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, equities analysts anticipate that athenahealth, Inc. will post $1.97 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “athenahealth, Inc. (ATHN) Director Sells $104,000.00 in Stock” was first reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/10/24/athenahealth-inc-athn-director-sells-104000-00-in-stock.html.

Several institutional investors have recently added to or reduced their stakes in the stock. Comerica Bank boosted its position in shares of athenahealth by 0.6% in the 1st quarter. Comerica Bank now owns 2,487 shares of the health services provider’s stock worth $302,000 after buying an additional 14 shares in the last quarter. Advisor Group Inc. boosted its position in shares of athenahealth by 2.8% in the 2nd quarter. Advisor Group Inc. now owns 1,744 shares of the health services provider’s stock worth $244,000 after buying an additional 47 shares in the last quarter. Seven Bridges Advisors LLC boosted its position in shares of athenahealth by 5.4% in the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after buying an additional 67 shares in the last quarter. Teacher Retirement System of Texas boosted its position in shares of athenahealth by 2.2% in the 2nd quarter. Teacher Retirement System of Texas now owns 3,156 shares of the health services provider’s stock worth $444,000 after buying an additional 67 shares in the last quarter. Finally, State of Wisconsin Investment Board boosted its position in shares of athenahealth by 0.9% in the 2nd quarter. State of Wisconsin Investment Board now owns 7,868 shares of the health services provider’s stock worth $1,106,000 after buying an additional 70 shares in the last quarter.

ATHN has been the topic of a number of research reports. William Blair reiterated a “market perform” rating on shares of athenahealth in a research note on Friday, July 21st. Robert W. Baird reiterated a “buy” rating and issued a $170.00 price objective on shares of athenahealth in a research note on Thursday, August 31st. KeyCorp reiterated a “buy” rating and issued a $170.00 price objective on shares of athenahealth in a research note on Sunday, September 17th. Argus initiated coverage on shares of athenahealth in a research note on Friday, July 7th. They issued a “hold” rating on the stock. Finally, J P Morgan Chase & Co set a $136.00 price objective on shares of athenahealth and gave the stock a “hold” rating in a research note on Wednesday, July 19th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $144.91.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.